PRESS

Making an impact through innovation and breakthrough products.

Marathon Pharmaceuticals Announces Appointment of Marc Yoskowitz as Vice President of Business Development
DEERFIELD, Illinois | May 3, 2010

Former McKinsey Executive Joins Specialty Pharmaceutical Company.

Marathon Pharmaceuticals, LLC, a private-equity backed, fully-integrated specialty pharmaceutical company, announced today that it has appointed Marc Yoskowitz as Vice President of Business Development. Yoskowitz will be responsible for identifying, evaluating and executing corporate partnerships, strategic initiatives and new product opportunities

Prior to joining Marathon, Yoskowitz was an Associate Principal at McKinsey & Co. where he led McKinsey’s Midwest Corporate Finance Practice and was a member of the leadership team for the North American Pharmaceuticals and Medical Products Practice. His clients included a range of leading pharmaceutical companies, private equity and hedge funds. Yoskowitz’s roles included the development of value-add strategies, evaluation of potential partners and end-to-end deal team leadership across licensing, mergers and acquisition (M&A) and divestitures. Yoskowitz worked for three years as an M&A attorney at Davis, Polk & Wardwell in New York before joining McKinsey. He has a JD from Columbia University School of Law and BA from Washington University in St. Louis.

“Marc’s deep pharmaceutical experience and background in structuring, negotiating and executing deals will immediately accelerate our strategic partnering efforts as well as benefit our existing relationships,” said Robert S. Altman, Ph.D., president and chief executive officer of Marathon Pharmaceuticals. “We are extremely fortunate to have someone of Marc’s caliber on board and his talents in this area will be instrumental in enabling Marathon to bring more critical therapies to the patients who need them.”

About Marathon Pharmaceuticals

Marathon Pharmaceuticals is a private equity-backed, fully-integrated specialty pharmaceutical company headquartered in Deerfield, IL. Marathon currently develops, manufactures and commercializes branded prescription pharmaceutical products that address key unmet medical needs to improve the lives of small, often overlooked patient populations. Marathon has multiple marketed products across therapeutic areas to complement its early and late stage clinical development programs.

Product Acquisitions

Are you selling a product that is in late-stage approval or already on the market? Learn more >>

Strategic Partnerships